China has approved the world’s first commercial brain chip technology, called NEO, in a development that could transform treatment options for stroke patients. The technology is designed to help people regain hand movement by connecting brain activity with assistive robotic devices.
According to reports, the NEO brain chip can be implanted without damaging brain tissue. The device works by detecting and interpreting neural signals generated by the brain. These signals are then transmitted to a robotic glove, allowing users to control hand movements through their thoughts.
The approval marks a significant milestone in the field of brain-computer interface technology. Researchers believe the system could offer new possibilities for individuals who have lost mobility due to stroke and other neurological conditions. By converting brain signals into physical actions, the technology aims to improve independence and quality of life for patients.
Medical experts and technology researchers are closely watching the development as brain-chip technology continues to advance around the world. The approval also highlights growing efforts to combine neuroscience and artificial intelligence to address major healthcare challenges.
The launch of NEO represents an important step in medical innovation and offers new hope for patients seeking advanced solutions to restore movement and improve daily life.
0 Comments